| View |
|
DRP-14300-01
|
Doxofylline
|
Zefillin
|
400 mg
|
Tablet
|
Drug for Obstructive Airway Diseases (Xanthine)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 June 2024
|
14 August 2028
|
| View |
|
DRP-14330-01
|
Docetaxel
|
Doxetacent
|
20 mg/ mL (100 mg/ 5 mL)
|
Concentrate Solution for Infusion (I.V.)
|
Antineoplastic Agent
|
Getwell Pharma India Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
21 August 2028
|
| View |
|
DRP-14331-01
|
Docetaxel
|
Doxebest-RTU
|
20 mg/mL (80 mg/4 mL)
|
Concentrate Solution for Infusion (I.V.)
|
Antineoplastic Agent
|
Getwell Pharma India Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
23 August 2028
|
| View |
|
DRP-14375-06
|
Dutasteride + Tamsulosin Hydrochloride
|
Dutasdrom
|
500 mcg/400 mcg
|
Capsule
|
Benign Prostatic Hypertrophy Drug (Alpha-Adrenoreceptor Antagonist)
|
Pell Tech Health Care Private Ltd.
|
India
|
CLIDP Conversion
|
12 June 2024
|
31 August 2028
|
| View |
|
DRP-1454-07
|
Losartan Potassium
|
Losa Speed 100
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Interphil Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 June 2024
|
20 February 2029
|
| View |
|
DRP-14604-01
|
Nebivolol (as hydrochloride)
|
Nebi-Flow
|
2.5 mg
|
Tablet
|
Selective Beta-Blocking Agent
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
26 October 2028
|
| View |
|
DRP-14624-01
|
Solifenacin Succinate
|
Soligen
|
5 mg
|
Film-Coated Tablet
|
Selective M3 Antimuscarinic Receptor Antagonist
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
10 November 2028
|
| View |
|
DRP-14658-01
|
Aripiprazole
|
Arpip
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Nobel ?laç Sanayii ve Ticaret A.?
|
Turkey
|
CLIDP Conversion
|
15 June 2024
|
17 November 2028
|
| View |
|
DRP-14686-0
|
Losartan Potassium + Amlodipine (as besilate)
|
Tozam 100/5
|
100 mg / 5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blockers (ARB) / Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 June 2024
|
23 November 2028
|
| View |
|
DRP-14737-01
|
Nicardipine Hydrochloride
|
Nicardize
|
1 mg / mL (10 mg/10 mL)
|
Solution for Injection (IV)
|
Calcium Channel Blocker
|
BC World Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
11 June 2024
|
13 October 2026
|
| View |
|
DRP-14777-04
|
Norepinephrine (as bitartrate)
|
Nepriqo 4
|
1 mg / ml (4 mg/4 ml)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic / Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
11 June 2024
|
03 January 2029
|
| View |
|
DRP-14784-01
|
Carboplatin
|
Carboget
|
150 mg/ 15 mL (10 mg/ mL)
|
Solution for Intravenous Infusion
|
Antineoplastic Agent
|
Venus Remedies Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
04 January 2029
|
| View |
|
DRP-1551-03
|
Docusate Sodium
|
Docoset
|
5 mg / mL (0.5%)
|
Ear Drops
|
Ceruminolytic
|
Ashford Pharmaceutical Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 June 2024
|
21 July 2029
|
| View |
|
DRP-2239-01
|
Paclitaxel
|
Taxelbene
|
6 mg/mL (30 mg/5 mL)
|
Solution for Intravenous Infusion
|
Antineoplastic (Taxane)
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
04 June 2025
|
| View |
|
DRP-2241-01
|
Paclitaxel
|
Taxelbene
|
6 mg/mL ( 100 mg/ 16. 7 mL)
|
Solution for Intravenous Infusion
|
Antineoplastic (Taxane)
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
04 June 2025
|
| View |
|
DRP-2367-01
|
Oxaliplatin
|
Colorebene
|
100 mg
|
Lyophilized Powder for Solution for I.V. Infusion
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
30 July 2025
|
| View |
|
DRP-2901-05
|
Olanzapine
|
Plomorazine
|
10 mg
|
Film-Coated Tablet
|
Anti-psychotic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
11 April 2029
|
| View |
|
DRP-4317-03
|
Methylprednisolone (as sodium succinate)
|
Predhil
|
1 g
|
Powder for Injection (IV)
|
Corticosteroid
|
United Biotech (P) Ltd.
|
India
|
CLIDP Conversion
|
12 June 2024
|
17 October 2027
|
| View |
|
DRP-4771-08
|
Co-Amoxiclav
|
J-Mox
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Giyaan Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 June 2024
|
02 October 2028
|
| View |
|
DRP-4891-02
|
Capecitabine
|
Carbabene
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic (Pyrimidine analogue)
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
29 November 2025
|